Office-use compounding in Missouri

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The exception is a dispensed prescription, not office stockHigh confidence

Subsection (12) permits supply to a prescriber to administer, but only to an individual patient and only by a prescription the pharmacy dispensed. That is patient-specific fulfilment delivered to a clinic — the arrangement most often mistaken for office use — and it is the only thing the exception reaches.

"Except as provided by law" points at law that does not existHigh confidence

The savings clause opening (12) has nothing to save. Unlike the states that route the question to federal law, Missouri does not incorporate the federal compounding provisions, and they would not help if it did: the federal exemptions themselves turn on an identified individual patient and a valid prescription order.

The veterinary carve-out is affirmative evidence, not an absence of itHigh confidence

Subsection (13) is a complete, working office-stock rule: non-patient-specific preparations, supplied to a Missouri-licensed veterinarian, to administer and dispense to animal patients, under a prescribed container label that includes the words "Office Stock Compounded Preparation". The Board knew how to build this and built it for animals only. This is the same shape as Louisiana, and Missouri is the second clean instance of it in this file.

The one non-patient-specific human limb is a hospital shortage ruleHigh confidence

20 CSR 2220-2.410(1), effective 30 September 2023, lets Class B hospital pharmacies compound shortage medications without a patient-specific prescription — on documented unavailability, for administration within the same hospital system only, in the same dosage form and strength, in a quantity not exceeding seven days of anticipated need, stopping once the product is available again, and labelled "Pharmacy Compounded Preparation". It is not a general office-use door and cannot be read as one.

Anticipatory batching is capped, and exceeding the cap changes the categoryHigh confidence

20 CSR 2220-2.400(7)(C) permits limited quantities only on a history of receiving valid prescriptions, and defines a limited quantity as a batch representing a three-month supply — one year for external creams, ointments, lotions and liniments. Exceeding it "shall be considered manufacturing instead of compounding", which moves the activity into a different licence category entirely.

Delivery to a clinic is lawful, and that is not the same questionHigh confidence

20 CSR 2220-2.013(1)–(2) bars leaving or delivering filled prescriptions at an unlicensed location, then permits delivery of a filled prescription for an individual patient to the office of a licensed health care practitioner at the request of the patient or the patient’s designee. So the courier route to a clinic exists — it just carries named-patient product.

No label legend and no "office use" language on the human sideHigh confidence

Missouri prescribes no "not for resale" or "office use only" wording for human preparations, and the phrase "office use" returns no hits in operative text across the pharmacy, controlled-substance, facility and physician provisions. The only office-stock legend in Missouri law is the veterinary one.

Missouri has two 5% clauses and one of them runs backwardsHigh confidence

RSMo 338.315.2 permits a pharmacy to sell, purchase or trade prescription drugs with other pharmacies where the volume stays under five percent of its total annual prescription drug sales. RSMo 338.330(4) defines a "pharmacy distributor" as a pharmacy delivering legend drugs to another pharmacy where that constitutes at least five percent of total gross sales — an inclusion trigger, not an exemption. Crossing the threshold is what MAKES a pharmacy licensable there.Three reasons neither helps, and this is sharper than the general warning. Both run pharmacy to pharmacy and neither reaches a practitioner, so the usual false friend is not even available in Missouri. Anyone citing § 338.330(4) as "Missouri’s 5% exemption" has inverted the statute. And § 338.315.2 is a licensure and criminal safe harbour that leaves 20 CSR 2220-2.400(12) untouched at any volume. A third clause on the controlled-substance side excuses a dispenser distributing under five percent of total dosage units from a separate distributing registration — same shape, same answer.

Entity or person — no entity credential exists on the medical sideHigh confidence

Missouri encodes the corporate practice of medicine in a definition: RSMo 356.021(5)(a) describes a professional service as one that may lawfully be rendered only by licensed persons and may not lawfully be rendered by an ordinary business corporation, with ownership locked to licensees. The pharmacy permit and the distributor licence are expressly entity-capable; the authority to practise medicine is not, and there is no permit a Missouri medical company can apply for that authorises it to hold drug stock in its own right.One adjacent tripwire for any office-use business model: RSMo 334.100.2(22) makes it grounds for discipline for a physician to require, as a condition of the physician-patient relationship, that the patient receive prescribed drugs, devices or other professional services directly from facilities of that physician’s office or other entities under that physician’s ownership or control.

Where office stock is channelled insteadHigh confidence

20 CSR 2220-5.030(1) requires drug distributors to maintain standards ensuring that only drugs of appropriate quality are distributed to practitioners for further compounding and dispensing. The lawful channel to a Missouri prescriber therefore runs through the distributor licence rather than the pharmacy permit — and a licensed drug outsourcer is the intended occupant of it.

Last changeHigh confidence

The office-use prohibition is unchanged. RSMo 338.010 contains no office-use provision in any subsection and its 2026 amendments are vaccine-related, so any brief asserting that section speaks to office use is wrong — the operative text lives entirely in the Board’s rule. Missouri introduced no office-use, non-patient-specific or outsourcing-facility bill in either the 2025 or the 2026 session.A sterile-compounding overhaul at 20 CSR 2220-2.200 was adopted on 1 June 2026, effective thirty days after publication, adopting the USP sterile chapter wholesale but expressly excluding its immediate-use and allergen-extract exemptions. It raises the bar on all sterile work and does not touch the office-use prohibition.

Missouri at a glance

Receiving 503B office stock in Missouri

The outsourcing-facility route is open in Missouri and it is licensed per site by the Board of Pharmacy — but the category is not called what a searcher expects, the 2026 reciprocity easement deliberately leaves it out, and the controlled-substance registrar is a different state department that must be dealt with before the federal one.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Missouri asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

A "drug outsourcer" licence from the Missouri Board of Pharmacy, which sits in the Department of Commerce and Insurance. RSMo 338.330(1) defines a drug outsourcer as an outsourcing facility as defined by the federal outsourcing-facility section; RSMo 338.333.1 bars anyone acting as one without a licence and requires separate licences for each distribution site; and RSMo 338.337 makes it unlawful for an out-of-state drug outsourcer to do business in the state without first obtaining a licence. Since 28 August 2025, RSMo 338.052 adds state and federal fingerprint-based background checks reaching licensees, facility managers and owners above a ten percent stake.Two traps make this harder than it looks. Searching Missouri law for "outsourcing facility" turns up one definitional cross-reference and can leave the impression that no category exists; the category is "drug outsourcer", and the Board’s form is titled for it. And the 2026 accreditation-reciprocity easement at § 338.333.3(1), in force since 28 August 2026, extends only to out-of-state wholesale drug distributors and third-party logistics providers — every other sentence in the statute lists all four categories and this one omits drug outsourcers, so a full non-reciprocal Missouri licence is still required. A pharmacy shipping patient-specific product needs a different credential again: a non-resident pharmacy licence.

Does your practice need a permit?Medium confidence

No. RSMo 338.010.4 exempts a legally registered practitioner of medicine, dentistry or podiatry in the compounding, administering, prescribing or dispensing of their own prescriptions, and RSMo 338.220.1 requires a permit only to open, establish, operate or maintain a pharmacy.Marked medium because no Missouri authority says this expressly for office stock — it is an inference from two provisions read together. Do not confuse the answer with the "Class P: practitioner office/clinic" permit, which is a permit for a pharmacy located inside a clinic and operating solely for that practitioner’s patients. It is not a permit to hold office stock.

Administer vs dispenseMedium confidence

The practitioner exemption in RSMo 338.010.4 covers compounding, administering, prescribing and dispensing of the practitioner’s own prescriptions, so the line matters less to the permit question here than in most states. It matters to the supply question instead: what a pharmacy may lawfully send is fixed by 20 CSR 2220-2.400(12) regardless of what the practice then does with it.

Scheduled (controlled) stockHigh confidence

Yes, from a second department, and before the federal registration. RSMo 195.030.2 bars manufacturing, compounding, distributing, dispensing or prescribing a controlled substance without first obtaining a registration issued by the Department of Health and Senior Services — the Bureau of Narcotics and Dangerous Drugs — and § 195.030.6 requires a separate registration at each principal place of business or professional practice. Physicians cannot ride an entity’s registration: § 195.030.4(1) excludes them from the agent-and-employee exemption, and the rule issues practitioner registrations to an individual practitioner at a Missouri practice location.Two agencies in two departments, and a facility shipping controlled substances into Missouri needs both. The bureau’s reach is limited to controlled substances — its own guidance says it has no authority over non-controlled drugs — so for compounded peptides, hormones and other legend drugs it is usually out of the path entirely.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• We have not fetched the Board of Pharmacy’s own guidance interpreting 20 CSR 2220-2.400(12). The verdict here rests on the rule text, which is unambiguous, but a board reading could add conditions around it.
• Whether the out-of-state inspection shortcut in RSMo 338.337 reaches a drug outsourcer is unresolved. That sentence exempts only an out-of-state wholesale drug distributor that is a drug manufacturer, and drug outsourcers are separately enumerated throughout the section without being named in the exemption. That is an inference from the enumeration pattern, and no Missouri authority construes it.
• That a physician practice needs no permit to hold office stock is read from two provisions together rather than stated anywhere. It is the weakest link on this page’s receiving side.
• The permanent effective dates of five 2026 rulemakings, including the sterile-compounding overhaul, are unconfirmed. Tax treatment of drugs a practice buys and administers was researched and is deliberately not published here: a tax is not a credential, it authorises nothing, and a Missouri letter ruling binds the department only as to its own applicant.
• We searched no case law, attorney-general opinions or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.